Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

Figure 1

Box plots show 5th/95th percentiles of antibody response, that is, ratio of postvaccination/prevaccination antibody levels for 6B and 23F in different treatment groups. Statistically significant differences in antibody response for each serotype when two different treatment groups were compared (Mann-Whitney U-test) are indicated. MTX, methotrexate; Spondylart, spondyloarthritis; NSAID, non-steroidal anti-inflammatory drug.

Back to article page